SEC Form 4 · accession 0001567619-18-004358
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Adam Havey
Officer — EVP, Business Operations
Period of report
Oct 17, 2018
Accepted (ET)
Oct 19, 2018 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 17, 2018 | M | 314 | $25.62 | A | 29,567 | D | |
| Common StockF1 | Oct 17, 2018 | S | 314 | $61.50 | D | 29,253 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2,F1,F3 | $25.62 | Oct 17, 2018 | M | 314 | D | — | Mar 10, 2021 | Common Stock | 314 | 8,179 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- F2Consists of an option granted under the company's stock incentive plan as amended and restated.
- F3The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant.